Catheter Precision (VTAK) Restructuring Costs (2022)
Catheter Precision (VTAK) posted quarterly Restructuring Costs of -$3.2 million for Q4 2022, down 451.0% quarter-over-quarter from $900000.0 in Q3 2022.
Catheter Precision (VTAK) Restructuring Costs (2022) Analysis & Trends
Catheter Precision (VTAK) has reported Restructuring Costs for 1 consecutive years, with -$3.2 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Restructuring Costs changed N/A year-over-year to -$3.2 million; the TTM figure through Sep 2023 stood at -$2.3 million (changed N/A YoY), while the FY2022 annual figure was $910000.0, changed N/A from the prior year.
- Restructuring Costs fell to -$3.2 million in Q4 2022 per VTAK's latest filing, from $900000.0 in the prior quarter.
- Across five years, Restructuring Costs topped out at $3.5 million in Q2 2022 and bottomed at -$3.2 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 130.69 Bn | 127.22 Bn | 4.50 Bn |
| 3 | Medtronic | 120.89 Bn | 111.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 75.26 Bn | 74.72 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.88 Bn | 48.63 Bn | 1.35 Bn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.47 Bn | 23.15 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn |
| 10 | Catheter Precision | 572,444.98 | -1.27 Mn | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3.16 Mn |
| Sep 30, 2022 | 900,000.00 |
| Jun 30, 2022 | 3.53 Mn |